241 related articles for article (PubMed ID: 10072560)
1. HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines.
Wilson CC; Olson WC; Tuting T; Rinaldo CR; Lotze MT; Storkus WJ
J Immunol; 1999 Mar; 162(5):3070-8. PubMed ID: 10072560
[TBL] [Abstract][Full Text] [Related]
2. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.
Tüting T; Wilson CC; Martin DM; Kasamon YL; Rowles J; Ma DI; Slingluff CL; Wagner SN; van der Bruggen P; Baar J; Lotze MT; Storkus WJ
J Immunol; 1998 Feb; 160(3):1139-47. PubMed ID: 9570527
[TBL] [Abstract][Full Text] [Related]
3. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
4. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
Macatonia SE; Patterson S; Knight SC
Immunology; 1991 Nov; 74(3):399-406. PubMed ID: 1769689
[TBL] [Abstract][Full Text] [Related]
5. Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donors.
Philip R; Brunette E; Ashton J; Alters S; Gadea J; Sorich M; Yau J; O'Donoghue G; Lebkowski J; Okarma T; Philip M
Cancer Gene Ther; 1998; 5(4):236-46. PubMed ID: 9694075
[TBL] [Abstract][Full Text] [Related]
6. Induction of primary human CD8+ T lymphocyte responses in vitro using dendritic cells.
Zarling AL; Johnson JG; Hoffman RW; Lee DR
J Immunol; 1999 May; 162(9):5197-204. PubMed ID: 10227993
[TBL] [Abstract][Full Text] [Related]
7. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
[TBL] [Abstract][Full Text] [Related]
8. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection.
Fan Z; Huang XL; Zheng L; Wilson C; Borowski L; Liebmann J; Gupta P; Margolick J; Rinaldo C
J Immunol; 1997 Nov; 159(10):4973-82. PubMed ID: 9366424
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
10. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
[TBL] [Abstract][Full Text] [Related]
12. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
[TBL] [Abstract][Full Text] [Related]
14. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes.
van Baalen CA; Guillon C; van Baalen M; Verschuren EJ; Boers PH; Osterhaus AD; Gruters RA
Eur J Immunol; 2002 Sep; 32(9):2644-52. PubMed ID: 12207349
[TBL] [Abstract][Full Text] [Related]
15. Carboxyl-terminal and central regions of human immunodeficiency virus-1 NEF recognized by cytotoxic T lymphocytes from lymphoid organs. An in vitro limiting dilution analysis.
Hadida F; Parrot A; Kieny MP; Sadat-Sowti B; Mayaud C; Debre P; Autran B
J Clin Invest; 1992 Jan; 89(1):53-60. PubMed ID: 1370302
[TBL] [Abstract][Full Text] [Related]
16. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
17. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
[TBL] [Abstract][Full Text] [Related]
18. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
Correale P; Micheli L; Vecchio MT; Sabatino M; Petrioli R; Pozzessere D; Marsili S; Giorgi G; Lozzi L; Neri P; Francini G
Br J Cancer; 2001 Nov; 85(11):1722-30. PubMed ID: 11742494
[TBL] [Abstract][Full Text] [Related]
19. HLA-dependent variations in human immunodeficiency virus Nef protein alter peptide/HLA binding.
Couillin I; Connan F; Culmann-Penciolelli B; Gomard E; Guillet JG; Choppin J
Eur J Immunol; 1995 Mar; 25(3):728-32. PubMed ID: 7705402
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]